• 제목/요약/키워드: Korean-Chinese herbal medicines

검색결과 121건 처리시간 0.026초

쥐방울과 한약의 수치에 따른 aristolochic acid 함량변화 (Quantitative Change of Aristolochic Acid Contents by Processing Methods on the Plants of Aristolochiaceae)

  • 김민석;이정복;박시형;김동욱;민오진;류동영
    • 생약학회지
    • /
    • 제38권2호통권149호
    • /
    • pp.123-127
    • /
    • 2007
  • Aristolochic acid (AA) included in the plants Aristolochiaceae have been well known to be nephrotoxic and carcinogenic inducer and to cause renal disease such as Chinese Herb Nephropathy (CHN). In this study, we used a high performance liquid chromatopaphy-mass spectrometry (HPLC-MS) under the positive ion detection mode for the quantitative change of aristolochic acid-I and-II (AA-I and AA-II) in Aristolochiaceae (Aristolochia contorta Bunge, Aristolochia debilis Sieb. et Zucc., Aristolochia fangchi Wu), some related plants (Cocculus trilobus De candolle, Inula helenium Linne, Saussurea lappa Clarke), and its prescriptions (防己茯笭湯, 定喘散) with or without processing. Here, the processing methods and prescriptions in oriental medicine were generally used to alleviate toxicity or alter property of herbal medicines. However, the concentrations of AA-I and AA-II were highly determined in processed material extracts rather than unprocessed those, not measured in some related plants. Also, the concentrations of AA-I and AA-II even at the prescriptions mixed the plants of Aristolochiaceae were detected to range from 0.73 to 2.53 ppm. Thus, the present results suggest that the content of AA-I and AA-II contained to plants of Aristolochiaceae was not reduced by the processing methods or prescriptions which can induce the physico-chemical change and pharmacological transformation in traditional herbal medicines.

방광암(膀胱癌)의 한의학적 진료지침 개발을 위한 기초 연구 (A Preliminary Study for the Development of Clinical Practice Guidelines of Korean Medicine for Bladder Cancer)

  • 박태열;유화승;이상헌
    • 대한한방내과학회지
    • /
    • 제37권6호
    • /
    • pp.911-928
    • /
    • 2016
  • Objectives: This study presents Korean medicine clinical practice guidelines for bladder cancer, of which the 5-year survival rate has still been about 75% since the 1990s despite the rapid development of medical science. Methods: A consensus was reached by an expert committee composed of professors and researchers who specialize in Korean medicine on the basis of a literature review that included other countries' clinical guidelines and a textbook. Results: Traditional Chinese medicine clinical practice guidelines were published for the first time in 2014. In Korea, the medical system is different from China in that Korea has completely dualized Korean and Western medicine and a low availability of proprietary herbal medicines. Therefore, these Korean medicine clinical practice guidelines for treating bladder cancer based on the previously published guidelines of Chinese medicine will help first-line Korean medicine doctors. Conclusions: Further studies related to Korean medicine are necessary to develop more advanced Korean medicine clinical practice guidelines for treating bladder cancer.

일반적(一般的)으로 오용(誤用)된 생약종(生藥種)의 평가(評價) (Evaluation of the Commonly Misused Chinese Crude Drug Species)

  • 장영훈
    • 혜화의학회지
    • /
    • 제4권2호
    • /
    • pp.333-333
    • /
    • 1996
  • Chinese medicine is a precious treasure inherited from ancient ancestors. It is accredited for the prosperous growth of the Chinese nations. However, the descriptions of the herbs in the ancient herbal are not in detail and the great numbers of herbs used which grows in wide geographic areas together with various local folk names, new substitutes and new folk medicines had increased, many Chinese herbs are composed of herbs that are labeled with identical names but actually are of different origins and different grades. Similar situation had occurred in China, japan and Korea In Taiwan, misused Chinese crude drugs are also very common in the past. This phenomenon had caused a lot of confusion and had great influence the clinical efficacy of the treatment. In the past, Professor Hong Yen Hsu, Na Chi, Woei Song Kan and Kung Yin Yen had studied the origins of Chinese crude drugs in Taiwan based on the morphological identification and found that the origins of Ma-Tou-Ling, Pu-Kung-Yin, Tu-Chung, Wang-Pu-Liu-Hsing, Pan-lan-Ken, Niu-Chi, Fang-Chi, Huang-Chi, PienHsiu and Sha Wan-Tzi are different from that of the species used in mainland China. In order to assure the quality and clinical efficacy of the crude drugs, besides the traditional morphological methods, we bad recently combined modem chemical and pharma-cological methods to assess drug quality. Drugs that have been evaluated without effects should be abandoned. The species of those commonly misued crude drugs used in compound formula preparations are also identified Based on the pharmacological results, a suitable species is recommended so as to improve the clinical efficacy of those preparations. In this paper, we like to report our recent studies on Niu Chi(Achyranthis Bidentatae Radix, Cyathulae Radix and Strobilanthis Radix). Fang-Chi(Arstolochiae Fangchi Radix, Stephaniae Tetrandrae Radix and Cocculus Radix) and Huang-Chi(Astragali Radix and Hedysari Radix) using comparative pharmacognosy methods.

  • PDF

한약재 생산 및 품질부문의 ISO국제표준화 등재현황 소개 및 대응방안 고찰 (Introduction of the International Standardization of ISO in the Production and Quality of Herbal Medicines and a Review of Countermeasures)

  • 김용일;강영민;한신희;허목;김영국;장재기
    • 한국국제농업개발학회지
    • /
    • 제30권4호
    • /
    • pp.257-268
    • /
    • 2018
  • 본고에서는 최근 중국을 중심으로 추진되고 있는 한약재 ISO 국제표준화에 대한 대응을 위해 최신 등재 현황을 소개하고 주요 추진상의 문제점과 대응방안들을 점검해 보았다. 주요 내용을 정리하면 다음과 같다. 1. 국제표준화기구 전통의학 기술위원회(ISO TC249)는 2009년 설립이후 31개의 국가가 참여하여 한약재 국제표준화를 추진하고 있다. 한 중 일은 발의 문건은 90%이상을 차지하여 사실상 아시아의 전통의학 분야를 두고 경쟁하고 있으며 간사국인 중국은 약용작물의 종자 종묘에서부터 약재의 생산, 품질 그리고 침구, 의료기술 등에 이르기까지 전 한방분야에서 표준화를 주도하고 있다. 현재 진행되고 있는 약용작물 재배 및 한약재 품질 관련 안건만 약 50여건에 달해 향후 5년 내에 시장 거래량 상위품목들의 국제표준화 작업이 대부분 완료될 것으로 예상된다. 2. 현재 진행되고 있는 안건들은 한약재의 품질이나 품질평가에 관한 안건들이 대부분이다. 이 안건들이 국제표준으로 인정되면 세계 한약재 유통시장에는 새로운 질서와 우열기준이 생기고 유통 한약재의 시장가치 평가에 반영되어 각국 한약재 점유율 변동에도 영향을 줄 수 있다. 이들 안건들은 직접적인 재배생산 표준이 아닌 경우가 대부분이지만 성분이나 성상 등에 대한 표준을 담고 있으므로 대부분 재배생산과도 밀접한 관련이 있다. 만일 중국 중심의 표준화가 계속해서 심화된다면 장기적으로는 국내 생산농가에 부담을 줄 수도 있다. 그러므로 한약재 국제표준화 대응은 향후 국내 생산물이 표준규격을 달성할 수 있는 범위내로 기준을 유도하는 전략을 펴야 할 것이다. 이를 위해 국내 생산물의 특성을 파악하고 선반영 하려는 노력이 필요하다. 3. 한약재 표준화 대응은 중국의 추진안건이 많으므로 분야별 파급영향을 고려한 선별적인 대응이 필요하다. 종자 종묘 등 추가적인 제한 필요성이 낮은 분야보다는 향후 시장에서 한 중 간 경쟁이 발생할 수 있는 분야에 집중하는 것이 중요하다. 원산지 변조, 농약 잔류량 이산화황 과다검출 등의 이력이 있는 약재들은 해당 표준을 강화하고 재배환경의 영향을 받을 수 있는 도지약재들의 경우 성상이나 지표성분 등에 대한 국내약재의 특성을 최대한 반영할 필요성이 있다. 곰팡이나 해충관리 등은 아직 각국의 관리규정이나 저온저장 시설 등 현장 인프라 구축이 충분치 않은 점들도 고려되어야 한다. 아직 국제표준을 추진하기 위한 국내의 연구결과들이 충분치 않은 부분들이 많으므로 추가적인 연구와 지원이 필요할 것이다.

주의력결핍${\cdot}$과잉행동장애의 한의학 치료동향 (2005-2006년 중국 임상 논문 중심으로) (A Review of Attention Deficit Hyperactivity Disorder in Traditional Chinese Medicine)

  • 박현철;강문수;김락형
    • 동의신경정신과학회지
    • /
    • 제18권2호
    • /
    • pp.35-44
    • /
    • 2007
  • Objective : The purpose of this study is to take around the oriental medical treatment about Attention Deficit Hyperactivity Disorder in China. Method : We reviewed the 22 studies about ADHD which were published from 2005 to 2006. We selected those studies from CNKI (中國知識基礎設施工程 http://www.cnki.net). Result : We could find 22 studies about ADHD in CNKI from 2005 to 2006. DSM (III-R of IV) was used frequently in the diagnosis of ADHD. Herbal medicines, acupuncture, auricular therapy, moxibustion, chuna treatment, cupping therapy were used in the tre atments of ADHD. Differentiation of syndromes-Eum deficiency, heart and spleen deficiency, Damwha- was important in the diagnosis and treatments of ADHD in TCM. Jang and Bu(the internal organs; 臟腑) concerned in differentiation of syndromes about ADHD were Liver 肝, Kidney 賢, Heart 心, Spleen 脾. Most of studies reported very good results compared with western medicine treatment- Ritalin medication. Conclusion :There have been reported many ADHD clinical studies in China and these studies can be applied to the clinical practices in Korea.

  • PDF

Ancient herbal therapy: A brief history of Panax ginseng

  • Maria Assunta Potenza;Monica Montagnani;Luigi Santacroce;Ioannis Alexandros Charitos;Lucrezia Bottalico
    • Journal of Ginseng Research
    • /
    • 제47권3호
    • /
    • pp.359-365
    • /
    • 2023
  • Ginseng was the most revered of the herbs in ancient times in China, Korea, Japan, America. Ginseng was discovered over 5000 years ago in the mountains of Manchuria, China. References to ginseng are found in books dating back more than two millennia. It is revered by the Chinese people as it is considered a herb for everything use and therefore for a wide range of diseases (currently its Latin name derived from the Greek panacea, meanings, that is, for everything). So, it was used exclusively by the Chinese Emperor's, and they were willing to pay the price without problems. Increasing its fame, ginseng brought a flourishing international trade that allowed Korea to supply China with silk and medicines in exchange for wild ginseng and later along with what grows in America.

한약재 수치에 관한 연구(VIII) - 당고특대황으로부터 조제한 주초대황의 주성분 함량변화 - (Studies on the Processing of Herbal Medicines(VIII) - HPLC Analysis of Standard Compounds of Processed Rhei rhiaoma from root of R. Tanguticum -)

  • 이윤미;이상원;김현정;조정희;김진숙
    • 한국한의학연구원논문집
    • /
    • 제10권2호
    • /
    • pp.93-99
    • /
    • 2004
  • Rhei rhizoma was processed into Jucho Daewhang according to the method of chinese pharmacopoeia. The contents of Sennoside A, B, Aloe-emodin, Chrysophanol, Emodin, and Rhein were analyzed by HPLC.

  • PDF

오령산(五苓散)을 활용한 2개 증례 분석을 통한 『상한론(傷寒論)』 변병진단체계(辨病診斷體系) 응용에 관한 연구 (Research about application of Shanghanlun disease pattern identification diagnostic system to 2 cases treated by Oreong-san)

  • 박재경;임은교
    • 대한상한금궤의학회지
    • /
    • 제10권1호
    • /
    • pp.81-94
    • /
    • 2018
  • Objective : The objective of this study is to define the clinical meaning of Shanghanlun sentence by applying Shanghanlun disease pattern identification diagnostic system. Methods : 2 clinical cases, which were treated by Oreong-san according to Shanghanlun provisions dualized with Je-Gang(提綱) and Jo-Moon(條文), were analyzed. Results : According to the results of analysis of 2 cases, the patients' diseases were improved. The pain was decreased, and general weakness and anorexia were improved in 2 cases. Conclusions : These results suggests that the medicines from Shanghanlun are clinically effective when Shanghanlun is interpreted considering the origins of Chinese characters in the text, and Shanghanlun disease pattern identification diagnostic system is applied.

백강잠 추출물의 C57BL/6 마우스를 이용한 2주경구투여 독성시험 (Effects of a Two-Week-Oral-Toxicity Study of Bombyx batryticatus L. Extracts on C57BL/6 Mice)

  • 남현화;서윤수;문병철;이지혜;김용범;김중선
    • 대한본초학회지
    • /
    • 제35권2호
    • /
    • pp.47-53
    • /
    • 2020
  • Objectives : Bombyx batryticatus L. is the dried larval form of the silkworm (Bombyx mori L.) infected by Beauveria bassiania (Bals.) Vuill. It is used as a food and medicinal resource to treat asthma, headaches, epilepsy, and convulsions in traditional Korean and Chinese medicines. However, the research of the toxicity about B. batryticatus is not enough yet. Here, we investigate the effects of potential subacute toxicity following the repeated oral administration of B. batryticatus water extract to C57BL/6 mice, at various doses of 0, 50, 150, and 450 mg/kg/day during a two-week period. Methods : The following parameters were examined during the study period: body weight, gross findings, clinical signs, organ weight, hematology, serum biochemistry, histopathology, and mortality. At the end of the treatment period, all the mice were euthanized. Results : No changes were observed in the body weights, gross findings, clinical signs, organ weights, and mortality after two weeks of administration of the B. batryticatus extract. In addition, compared with the normal control group, no noticeable treatment-related changes were observed in the hematological, serum biochemical, and histopathological parameters in the treated group following treatment with doses of up to 450 mg/kg/day. Conclusion : Based on these findings, we conclude that the treatment of mice with the water extract of B. batryticatus did not cause considerable C57BL/6 toxicity, and therefore, it could be considered safe for further pharmacological studies.

중국에서의 약침을 활용한 불면증 치료 임상논문 연구동향 (A Review of a Clinical Study on Pharmacopuncture for Insomnia in China)

  • 송건의;임교민;이여경;송금주;박세진
    • 동의신경정신과학회지
    • /
    • 제30권3호
    • /
    • pp.265-274
    • /
    • 2019
  • Objectives: The purpose of this study was to research the trend related to pharmacopuncture for insomnia in China for further development of pharmacopuncture in Korea. Methods: This study reviewed and analyzed 21 Chinese journals related to pharmacopuncture 2013~2019 sourced with the following keywords in the China National Knowledge Infrastructure (CNKI). 'Shimian', 'Wuewei zhushe', 'Shuizhen', 'Xuewei yaowu zhushe', 'Yaowu xuewei zhushe', 'Xuewei zhuyao', 'Xuezhu', and 'Xueweiyaowu zhuru'. Results: The following results were obtained in this study. 1. A total of 21 papers were selected, comprised of clinical research and case reports. 2. Pharmacopuncture was often used for insomnia, and as the medicine of injection, Salvia, Gastrodin, Acanthopanax, Hominis Placenta, Qingkailing, Shenmai, Bozhi Glycopeptide, Fufang Danggui, Vitamin B12, and Chlorpromazine Hydrochloride were used. 3. In combined treatments, acupuncture, chiropractic, auricular sticking, and herbal medicine were used. 4. It was more effective compared to conservational acupuncture therapy. Conclusions: It was established that they have efficiency to treat insomnia with pharmacopuncture in China, but there were limitations in this study, so we need more research to identify new medicines for neuropsychiatric diseases.